Close Menu

NEW YORK – Natera said on Monday that it has filed a lawsuit against CareDx, claiming the company infringes its US Patent No. 10,526,658.

The patent, which was awarded Jan. 7, covers cell-free DNA-based diagnostic methods, including those used in transplant medicine, such as Natera's Prospera donor-derived cell-free DNA organ transplant test, which competes with CareDx's AlloSure test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.